Viewing Study NCT04206059


Ignite Creation Date: 2025-12-24 @ 2:41 PM
Ignite Modification Date: 2025-12-26 @ 3:25 AM
Study NCT ID: NCT04206059
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2022-12-02
First Post: 2019-12-09
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Closed Loop Acoustic Stimulation During Sedation With Dexmedetomidine
Sponsor: Washington University School of Medicine
Organization:

Study Overview

Official Title: Closed Loop Acoustic Stimulation During Sedation With Dexmedetomidine
Status: ACTIVE_NOT_RECRUITING
Status Verified Date: 2022-11
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: CLASS-D
Brief Summary: Prospective within-subject study of dexmedetomidine sedation paired with CLAS conditions in repeated blocks. Intervention will consist of CLAS in-phase with EEG slow waves. Anti-phase stimulation will serve as an active control while sham stimulation will serve as a passive control.
Detailed Description: Both nonpharmacologic and pharmacologic interventions augment expression of EEG slow waves that mimic those of natural sleep. Closed loop auditory stimulation (CLAS) is a noninvasive inexpensive approach to augment the spectral power and duration of these slow waves. Whether in-phase CLAS may address this need is unknown, since acoustic potentiation of pharmacologically-induced slow waves has not been investigated. This prospective within-subject study of dexmedetomidine sedation paired with CLAS will assess the feasibility of augmenting EEG slow waves during sedation.

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: True
Is an Unapproved Device?: True
Is a PPSD?: None
Is a US Export?: True
Is an FDA AA801 Violation?: